Why Hims & Hers Doesn’t Need “Nasty Novo”
Last Monday, Novo Nordisk cut ties with Hims & Hers Health (HIMS) after only two months, triggering a 35% price crash for HIMS stock and a war of words between the two company’s leadership. That’s why I worked up the video below for my three investing services where I have recommended HIMS stock (Green Zone Fortunes, 10X Stocks and here in Max Profit Alert).
Read More